Skip to main content

Vontobel Holding Ltd.

SEC CIK
0001588340
Latest filing
Aug 3, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Vontobel Holding Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
81,525
Value
$40.5M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of VRTX by Vontobel Holding Ltd., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202681,525$40.5M0.1%−1,855−2.2%ReducedHolders
Q1 202683,380$37.2M0.1%−21,907−20.8%ReducedHolders
Q4 2025105,287$47.7M0.2%−5,355−4.8%ReducedHolders
Q3 2025110,642$43.3M0.1%+38,844+54.1%AddedHolders
Q2 202571,798$32.0M0.1%−3,008−4.0%ReducedHolders
Q1 202574,806$36.3M0.1%−114,143−60.4%ReducedHolders
Q4 2024188,949$76.1M0.3%+75,653+66.8%AddedHolders
Q3 2024113,296$52.7M0.2%−45,534−28.7%ReducedHolders
Q2 2024158,830$74.4M0.2%+50,450+46.5%AddedHolders
Q1 2024108,380$45.3M0.4%+46,946+76.4%AddedHolders
Q4 202361,434$25.0M0.2%−6,200−9.2%ReducedHolders
Q3 202367,634$23.5M0.2%−363−0.5%ReducedHolders
Q2 202367,997$23.9M0.2%+10,387+18.0%AddedHolders
Q1 202357,610$18.2M0.2%−5,089−8.1%ReducedHolders
Q4 202262,699$17.9M0.2%+3,573+6.0%AddedHolders
Q3 202259,126$17.3M0.2%−13,662−18.8%ReducedHolders
Q2 202272,788$20.4M0.2%−17,903−19.7%ReducedHolders
Q1 202290,691$23.3M0.2%−26,006−22.3%ReducedHolders
Q4 2021116,697$26.0M0.2%+18,953+19.4%AddedHolders
Q3 202197,744$17.7M0.2%+19,318+24.6%AddedHolders
Q2 202178,426$15.4M0.1%+11,786+17.7%AddedHolders
Q1 202166,640$14.3M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.